0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Assistive Reproductive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-2N1622
Home | Market Reports | Health| Reproductive Health
Global Assistive Reproductive Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Assistive Reproductive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2N1622
Report
October 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Assistive Reproductive - Market Size

The global market for Assistive Reproductive was estimated to be worth US$ 28150 million in 2023 and is forecast to a readjusted size of US$ 38130 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030

Assistive Reproductive - Market

Assistive Reproductive - Market

Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Assistive Reproductive, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Assistive Reproductive by region & country, by Type, and by Application.
The Assistive Reproductive market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assistive Reproductive.
Market Segmentation

Scope of Assistive Reproductive - Market Report

Report Metric Details
Report Name Assistive Reproductive - Market
Forecasted market size in 2030 US$ 38130 million
CAGR 4.6%
Forecasted years 2024 - 2030
Segment by Type:
  • In-vitro fertilization (IVF)
  • Artificial Insemination-Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Other
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Assistive Reproductive manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Assistive Reproductive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Assistive Reproductive in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Assistive Reproductive - Market size in 2030?

Ans: The Assistive Reproductive - Market size in 2030 will be US$ 38130 million.

Who are the main players in the Assistive Reproductive - Market report?

Ans: The main players in the Assistive Reproductive - Market are Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura

What are the Application segmentation covered in the Assistive Reproductive - Market report?

Ans: The Applications covered in the Assistive Reproductive - Market report are Fertility Clinics, IVF Center, Hospital

What are the Type segmentation covered in the Assistive Reproductive - Market report?

Ans: The Types covered in the Assistive Reproductive - Market report are In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other

Recommended Reports

IVF & ART Technologies

Infertility & Fertility

Assisted Surgery Devices

1 Market Overview
1.1 Assistive Reproductive Product Introduction
1.2 Global Assistive Reproductive Market Size Forecast
1.3 Assistive Reproductive Market Trends & Drivers
1.3.1 Assistive Reproductive Industry Trends
1.3.2 Assistive Reproductive Market Drivers & Opportunity
1.3.3 Assistive Reproductive Market Challenges
1.3.4 Assistive Reproductive Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Assistive Reproductive Players Revenue Ranking (2023)
2.2 Global Assistive Reproductive Revenue by Company (2019-2024)
2.3 Key Companies Assistive Reproductive Manufacturing Base Distribution and Headquarters
2.4 Key Companies Assistive Reproductive Product Offered
2.5 Key Companies Time to Begin Mass Production of Assistive Reproductive
2.6 Assistive Reproductive Market Competitive Analysis
2.6.1 Assistive Reproductive Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Assistive Reproductive Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assistive Reproductive as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 In-vitro fertilization (IVF)
3.1.2 Artificial Insemination-Intrauterine Insemination (AI-IUI)
3.1.3 Frozen Embryo Replacement (FER)
3.1.4 Other
3.2 Global Assistive Reproductive Sales Value by Type
3.2.1 Global Assistive Reproductive Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Assistive Reproductive Sales Value, by Type (2019-2030)
3.2.3 Global Assistive Reproductive Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fertility Clinics
4.1.2 IVF Center
4.1.3 Hospital
4.2 Global Assistive Reproductive Sales Value by Application
4.2.1 Global Assistive Reproductive Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Assistive Reproductive Sales Value, by Application (2019-2030)
4.2.3 Global Assistive Reproductive Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Assistive Reproductive Sales Value by Region
5.1.1 Global Assistive Reproductive Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Assistive Reproductive Sales Value by Region (2019-2024)
5.1.3 Global Assistive Reproductive Sales Value by Region (2025-2030)
5.1.4 Global Assistive Reproductive Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Assistive Reproductive Sales Value, 2019-2030
5.2.2 North America Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Assistive Reproductive Sales Value, 2019-2030
5.3.2 Europe Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Assistive Reproductive Sales Value, 2019-2030
5.4.2 Asia Pacific Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Assistive Reproductive Sales Value, 2019-2030
5.5.2 South America Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Assistive Reproductive Sales Value, 2019-2030
5.6.2 Middle East & Africa Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Assistive Reproductive Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Assistive Reproductive Sales Value
6.3 United States
6.3.1 United States Assistive Reproductive Sales Value, 2019-2030
6.3.2 United States Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Assistive Reproductive Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Assistive Reproductive Sales Value, 2019-2030
6.4.2 Europe Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Assistive Reproductive Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Assistive Reproductive Sales Value, 2019-2030
6.5.2 China Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.5.3 China Assistive Reproductive Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Assistive Reproductive Sales Value, 2019-2030
6.6.2 Japan Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Assistive Reproductive Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Assistive Reproductive Sales Value, 2019-2030
6.7.2 South Korea Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Assistive Reproductive Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Assistive Reproductive Sales Value, 2019-2030
6.8.2 Southeast Asia Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Assistive Reproductive Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Assistive Reproductive Sales Value, 2019-2030
6.9.2 India Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
6.9.3 India Assistive Reproductive Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cooper Surgical
7.1.1 Cooper Surgical Profile
7.1.2 Cooper Surgical Main Business
7.1.3 Cooper Surgical Assistive Reproductive Products, Services and Solutions
7.1.4 Cooper Surgical Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.1.5 Cooper Surgical Recent Developments
7.2 Hamilton Thorne
7.2.1 Hamilton Thorne Profile
7.2.2 Hamilton Thorne Main Business
7.2.3 Hamilton Thorne Assistive Reproductive Products, Services and Solutions
7.2.4 Hamilton Thorne Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.2.5 Hamilton Thorne Recent Developments
7.3 FUJIFILM Irvine Scientific
7.3.1 FUJIFILM Irvine Scientific Profile
7.3.2 FUJIFILM Irvine Scientific Main Business
7.3.3 FUJIFILM Irvine Scientific Assistive Reproductive Products, Services and Solutions
7.3.4 FUJIFILM Irvine Scientific Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.3.5 Nidacon International Recent Developments
7.4 Nidacon International
7.4.1 Nidacon International Profile
7.4.2 Nidacon International Main Business
7.4.3 Nidacon International Assistive Reproductive Products, Services and Solutions
7.4.4 Nidacon International Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.4.5 Nidacon International Recent Developments
7.5 Vitrolife AB
7.5.1 Vitrolife AB Profile
7.5.2 Vitrolife AB Main Business
7.5.3 Vitrolife AB Assistive Reproductive Products, Services and Solutions
7.5.4 Vitrolife AB Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.5.5 Vitrolife AB Recent Developments
7.6 Merck
7.6.1 Merck Profile
7.6.2 Merck Main Business
7.6.3 Merck Assistive Reproductive Products, Services and Solutions
7.6.4 Merck Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.6.5 Merck Recent Developments
7.7 INVO Bioscience
7.7.1 INVO Bioscience Profile
7.7.2 INVO Bioscience Main Business
7.7.3 INVO Bioscience Assistive Reproductive Products, Services and Solutions
7.7.4 INVO Bioscience Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.7.5 INVO Bioscience Recent Developments
7.8 IVFtech
7.8.1 IVFtech Profile
7.8.2 IVFtech Main Business
7.8.3 IVFtech Assistive Reproductive Products, Services and Solutions
7.8.4 IVFtech Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.8.5 IVFtech Recent Developments
7.9 Gonagen Medikal
7.9.1 Gonagen Medikal Profile
7.9.2 Gonagen Medikal Main Business
7.9.3 Gonagen Medikal Assistive Reproductive Products, Services and Solutions
7.9.4 Gonagen Medikal Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.9.5 Gonagen Medikal Recent Developments
7.10 Cook Medical
7.10.1 Cook Medical Profile
7.10.2 Cook Medical Main Business
7.10.3 Cook Medical Assistive Reproductive Products, Services and Solutions
7.10.4 Cook Medical Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.10.5 Cook Medical Recent Developments
7.11 CellCura
7.11.1 CellCura Profile
7.11.2 CellCura Main Business
7.11.3 CellCura Assistive Reproductive Products, Services and Solutions
7.11.4 CellCura Assistive Reproductive Revenue (US$ Million) & (2019-2024)
7.11.5 CellCura Recent Developments
8 Industry Chain Analysis
8.1 Assistive Reproductive Industrial Chain
8.2 Assistive Reproductive Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Assistive Reproductive Sales Model
8.5.2 Sales Channel
8.5.3 Assistive Reproductive Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Assistive Reproductive Market Trends
    Table 2. Assistive Reproductive Market Drivers & Opportunity
    Table 3. Assistive Reproductive Market Challenges
    Table 4. Assistive Reproductive Market Restraints
    Table 5. Global Assistive Reproductive Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Assistive Reproductive Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Assistive Reproductive Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Assistive Reproductive Product Type
    Table 9. Key Companies Time to Begin Mass Production of Assistive Reproductive
    Table 10. Global Assistive Reproductive Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assistive Reproductive as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Assistive Reproductive Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Assistive Reproductive Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Assistive Reproductive Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Assistive Reproductive Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Assistive Reproductive Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Assistive Reproductive Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Assistive Reproductive Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Assistive Reproductive Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Assistive Reproductive Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Assistive Reproductive Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Assistive Reproductive Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Assistive Reproductive Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Assistive Reproductive Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Assistive Reproductive Sales Value by Region (2019-2024) & (%)
    Table 27. Global Assistive Reproductive Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Assistive Reproductive Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Assistive Reproductive Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Assistive Reproductive Sales Value, (2025-2030) & (US$ Million)
    Table 31. Cooper Surgical Basic Information List
    Table 32. Cooper Surgical Description and Business Overview
    Table 33. Cooper Surgical Assistive Reproductive Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Assistive Reproductive Business of Cooper Surgical (2019-2024)
    Table 35. Cooper Surgical Recent Developments
    Table 36. Hamilton Thorne Basic Information List
    Table 37. Hamilton Thorne Description and Business Overview
    Table 38. Hamilton Thorne Assistive Reproductive Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Assistive Reproductive Business of Hamilton Thorne (2019-2024)
    Table 40. Hamilton Thorne Recent Developments
    Table 41. FUJIFILM Irvine Scientific Basic Information List
    Table 42. FUJIFILM Irvine Scientific Description and Business Overview
    Table 43. FUJIFILM Irvine Scientific Assistive Reproductive Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Assistive Reproductive Business of FUJIFILM Irvine Scientific (2019-2024)
    Table 45. FUJIFILM Irvine Scientific Recent Developments
    Table 46. Nidacon International Basic Information List
    Table 47. Nidacon International Description and Business Overview
    Table 48. Nidacon International Assistive Reproductive Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Assistive Reproductive Business of Nidacon International (2019-2024)
    Table 50. Nidacon International Recent Developments
    Table 51. Vitrolife AB Basic Information List
    Table 52. Vitrolife AB Description and Business Overview
    Table 53. Vitrolife AB Assistive Reproductive Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Assistive Reproductive Business of Vitrolife AB (2019-2024)
    Table 55. Vitrolife AB Recent Developments
    Table 56. Merck Basic Information List
    Table 57. Merck Description and Business Overview
    Table 58. Merck Assistive Reproductive Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Assistive Reproductive Business of Merck (2019-2024)
    Table 60. Merck Recent Developments
    Table 61. INVO Bioscience Basic Information List
    Table 62. INVO Bioscience Description and Business Overview
    Table 63. INVO Bioscience Assistive Reproductive Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Assistive Reproductive Business of INVO Bioscience (2019-2024)
    Table 65. INVO Bioscience Recent Developments
    Table 66. IVFtech Basic Information List
    Table 67. IVFtech Description and Business Overview
    Table 68. IVFtech Assistive Reproductive Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Assistive Reproductive Business of IVFtech (2019-2024)
    Table 70. IVFtech Recent Developments
    Table 71. Gonagen Medikal Basic Information List
    Table 72. Gonagen Medikal Description and Business Overview
    Table 73. Gonagen Medikal Assistive Reproductive Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Assistive Reproductive Business of Gonagen Medikal (2019-2024)
    Table 75. Gonagen Medikal Recent Developments
    Table 76. Cook Medical Basic Information List
    Table 77. Cook Medical Description and Business Overview
    Table 78. Cook Medical Assistive Reproductive Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Assistive Reproductive Business of Cook Medical (2019-2024)
    Table 80. Cook Medical Recent Developments
    Table 81. CellCura Basic Information List
    Table 82. CellCura Description and Business Overview
    Table 83. CellCura Assistive Reproductive Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Assistive Reproductive Business of CellCura (2019-2024)
    Table 85. CellCura Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Assistive Reproductive Downstream Customers
    Table 89. Assistive Reproductive Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Assistive Reproductive Product Picture
    Figure 2. Global Assistive Reproductive Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Assistive Reproductive Sales Value (2019-2030) & (US$ Million)
    Figure 4. Assistive Reproductive Report Years Considered
    Figure 5. Global Assistive Reproductive Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Assistive Reproductive Revenue in 2023
    Figure 7. Assistive Reproductive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. In-vitro fertilization (IVF) Picture
    Figure 9. Artificial Insemination-Intrauterine Insemination (AI-IUI) Picture
    Figure 10. Frozen Embryo Replacement (FER) Picture
    Figure 11. Other Picture
    Figure 12. Global Assistive Reproductive Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Assistive Reproductive Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Fertility Clinics
    Figure 15. Product Picture of IVF Center
    Figure 16. Product Picture of Hospital
    Figure 17. Global Assistive Reproductive Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Assistive Reproductive Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Assistive Reproductive Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Assistive Reproductive Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Assistive Reproductive Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Assistive Reproductive Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Assistive Reproductive Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Assistive Reproductive Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Assistive Reproductive Sales Value (%), (2019-2030)
    Figure 30. United States Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Assistive Reproductive Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Assistive Reproductive Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Assistive Reproductive Sales Value by Application (%), 2023 VS 2030
    Figure 51. Assistive Reproductive Industrial Chain
    Figure 52. Assistive Reproductive Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart